Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Scientific Reports|November 19, 2020
Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screenLina Schukur, Tamara Zimmermann, Ole Niewoehner, et al.Oncoimmunology|June 27, 2022
Combination of two novel blocking antibodies, anti-PD-1 antibody ezabenlimab (BI 754091) and anti-LAG-3 antibody BI 754111, leads to increased immune cell responsesMarkus Zettl, Melanie Wurm, Otmar Schaaf, et al.The Journal of Pharmacology and Experimental Therapeutics|January 11, 2015
Efficacy and mechanism of action of volasertib, a potent and selective inhibitor of Polo-like kinases, in preclinical models of acute myeloid leukemiaDorothea Rudolph, Maria Antonietta Impagnatiello, Claudia Blaukopf, et al.Cell|April 7, 2015
The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivoFlorian A Karreth, Markus Reschke, Anna Ruocco, et al.Nature Methods|April 9, 2008
BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammalsIna Poser, Mihail Sarov, James R A Hutchins, et al.Nature Medicine|April 8, 2015
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancerShuo Wei, Shingo Kozono, Lev Kats, et al.Science (New York, N.Y.)|April 3, 2010
Systematic analysis of human protein complexes identifies chromosome segregation proteinsJames R A Hutchins, Yusuke Toyoda, Björn Hegemann, et al.European Journal of Immunology|December 13, 2024
Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DCDiana Dudziak, Lukas Heger, William W Agace, et al.Human Molecular Genetics|September 1, 2018
Loss of LDAH associated with prostate cancer and hearing lossBenjamin B Currall, Ming Chen, Richard C Sallari, et al.European Journal of Immunology|December 13, 2022
Guidelines for DC preparation and flow cytometry analysis of mouse nonlymphoid tissuesHans Christian Probst, Patrizia Stoitzner, Lukas Amon, et al.Pageof 4